Discussion: I was shocked by a conversation (not meant for my ears) of the pharmaceutical company with my attending physician. I did not hear the whole discussion, but it was clear that my physician was financially motivated!

Medical promotion is a widespread phenomenon that exists under the surface without the patient being aware of it. Like other chronic patients, COPD patients take many medications regularly without being aware of the doctor's possible considerations in choosing the medicines. It is a question of medical ethics that the legislator does not deal with. (Not by chance)

Physicians' incentive for prescription drugs is widespread, seemingly contrary to the ethics rules, and circumvented in sophisticated ways. The doctor receives funding for conferences, trips, gifts, events, etc. In return, doctors aspire to provide the company's prescriptions. Medical campaigning is not outlawed and has no uniform and transparent rules. In cases where drug companies introduce a new drug, the rewards are even more generous! Is there a regulatory failure here? In my opinion, YES. Unfortunately, you will not find (to the best of my knowledge) primary legislation that prohibits this phenomenon.